Introduction
The transcription factor Jun belongs to the basic region/leucine zipper (bZip) protein family. Jun dimerizes with itself or with other bZip proteins to form the AP-1 transcription factor complex which recognizes the DNA target sequence TGACTCA (TRE sequence) and controls gene expression. Jun can induce oncogenic transformation; this activity requires the three basic functions of the protein: dimerization, DNA binding and transcriptional regulation (Morgan et al., 1992 ). An oncogenic version of Jun is transduced by the avian retrovirus ASV17 and is referred to as vJun (Bos et al., 1990; Maki et al., 1987) . It diers from its cellular counterpart by a 27-amino acid deletion and by two amino acid substitutions (Nishimura and Vogt, 1988) . These mutations synergize to make Jun independent of cellular regulation and to turn it into a strong growth promoter (Abate et al., 1990; Boyle et al., 1991; Chida and Vogt, 1992; Hibi et al., 1993; Morgan et al., 1993; 1994) .
v-Jun induces oncogenic transformation by aberrant regulation of speci®c target genes. The dierential expression of these targets determines the neoplastic phenotype of the cell. An understanding of transformation requires the identi®cation and characterization of these targets. Previous work has revealed several genes that are up-regulated in v-Jun-transformed avian cells including bkj (Hartl and Bister, 1995) , jtab (Hadman et al., 1996) , glutaredoxin (Goller et al., 1998) , hbegf (Fu et al., 1999) and ril (Fu et al., 2000) . These genes were identi®ed by various forms of substractive hybridization which typically cover only a small fraction of the transcriptome. More comprehensive expression pro®l-ing is provided by DNA micro-arrays, which are not yet available for avian genomes. Therefore, we established a murine transformation system for Jun. Primary rodent cells are refractory to Jun transformation, but some continuous mammalian cell lines are susceptible to the growth-promoting eects of Jun (Schutte et al., 1989) . We chose murine 10T1/2 cells to generate materials for DNA micro-array analysis. 10T1/2 cells were stably transformed with a retroviral vector expressing v-Jun. They became refractile, grew into multi-layered foci at high population densities and formed colonies when suspended in nutrient agar. mRNA from these v-Jun-transformed cells and from their normal 10T1/2 progenitors was used to identify up-and down-regulated genes in commercial DNA micro-arrays (Incyte Pharmaceuticals). This communication will characterize one of the down-regulated genes, SSeCKS (Src suppressed C kinase substrate). This myristylated protein is rapidly translocated from the cortical cytoskeletal matrix to the perinucleus in response to treatment with phorbol esters (Lin et al., 1996) . SSeCKS is down-regulated in rodent ®broblasts transformed by Src, Ras, Fos or Myc but shows unchanged levels of expression in cells transformed by Raf, Mos or Neu (Lin et al., 1995) . SSeCKS expression has also been found to be down-regulated in human breast cancer cell lines as compared to normal breast epithelial cells (Zhang et al., 1995) . Expression of SSeCKS in Src-transformed NIH3T3 cells has the eect of attenuating the transformed phenotype (Lin and Gelman, 1997 ). In the current study, expression of SSeCKS in v-Jun-transformed 10T1/2 cells induced a dramatic reduction of their oncogenic growth properties. These observations suggest that SSeCKS can function as a tumor suppressor.
Results

Expression of v-Jun in 10T1/2 cells causes morphological transformation
v-Jun is a highly eective oncogene for chicken embryo ®broblasts (CEF), inducing morphological transformation and robust anchorage-independent growth (Bos et al., 1990; Maki et al., 1987) . In primary mammalian cell cultures expressing v-Jun, such transformation is not observed, but continuous rodent cell lines are susceptible to transformation (Schutte et al., 1989) . In a comparison of several murine cell lines, 10T1/2 cells emerged as most sensitive to v-Jun-induced transformation and were therefore chosen for expression-pro®ling using commercially available DNA micro-array technology. For virus production, the chicken v-Jun cDNA without Gag sequences (VJ1), was subcloned into the pBabe-puro vector and transfected into the BOSC23 ecotropic packaging cell line. The replication-defective infectious viruses were then used to infect the amphotropic PA317 packaging cell line, and virus producers were selected with puromycin. Harvests from these cells were used to infect 10T1/2 cells, inducing a characteristic morphological transformation (Figure 1 ). Compared to controls infected with empty vector, vJun-expressing cells were round and refractile, appeared less adherent and grew in an irregular pattern.
v-Jun expressing 10T1/2 cells lose contact inhibition of growth and gain the ability to form colonies of agar 10T1/2 cells transformed by Jun multiplied initially at the same rate as control cells but they reached a far higher saturation density (Figure 2 ), forming sheets of multiple cell layers which have lost contact inhibition of growth. Focus formation on plastic support was assayed by plating various dilutions of v-Jun-transformed 10T1/2 cells together with a constant number of vector-transfected controls (Brugarolas et al., 1998) . Highly ecient focus formation was observed with vJun-expressing 10T1/2 cells; vector controls produced only a low background number of foci (Figure 3) .
In order to examine anchorage-independent growth, v-Jun-expressing cells were suspended in 0.35% nutrient agar. The number of colonies was determined after 4 weeks (Table 1 and Figure 4 ). Vector-infected cells did not grow in suspension, while v-Juntransformed 10T1/2 cells produced colonies with an eciency of greater than 30%.
SSeCKS expression is repressed in v-Jun-transformed 10T1/2 cells
The identi®cation of genes with altered expression patterns is critical to an understanding of oncogenic transformation. Expression-pro®ling was therefore performed with the v-Jun-transformed 10T1/2 cells. Four individual agar colonies were picked, expanded and used to generate poly(A) + RNA. DNA microarrays identi®ed 221 genes that are dierentially expressed by a factor of greater than two in v-Juntransformed cells; 147 were up-regulated, and 74 were down-regulated. Initial attention focused on the downregulated genes, because the signi®cance of the downregulation for transformation can be readily tested by reexpressing the gene in question. A partial listing of Figure 1 v-Jun-infection of 10T1/2 cells causes morphological transformation. 10T1/2 cells were infected with either p-Babepuro or p-Babe-puro-VJ1 virus and then selected with puromycin as described in Materials and methods. Cells were allowed to grow to con¯uency and photographed at 1006magni®cation with phase contrast optics Figure 2 v-Jun-transformation of 10T1/2 cells leads to increased saturation density that is attenuated by SSeCKS expression. 10T1/2 cells were infected with p-Babe-hygro-SSeCKS and VJ1 10T1/2 cells were super-infected with SSeCKS as described in Materials and methods. Cells were plated at 2610 4 cells in 35 mm plates, and counted every day for 9 days. The experiment was run three times, and a representative example is shown down-regulated v-Jun targets is given in Table 2 . One of these targets is the gene coding for SSeCKS. It was selected for characterization because it is known to be also down-regulated in cells transformed by Src, Ras, Fos, and Myc (Lin et al., 1995) and in cell lines derived from breast cancer (Zhang et al., 1995) . It has been classi®ed as tumor suppressor gene; re-expression leads to a reversion of the transformed phenotype in Srcexpressing cells without causing growth arrest (Lin and Gelman, 1997) . The degree of repression determined for SSeCKS in the DNA micro-arrays was 3.9-fold. A Northern blot with poly(A) RNA from v-Jun-transformed and from vector-transfected 10T1/2 cells showed an even greater repression, more than 10-fold ( Figure 5 ). Northern blots of other down-regulated targets revealed that the data from the DNA microarrays generally understate the degree of dierential expression. A Western blot was also prepared using cell lysates from v-Jun infected and control cells, and the quantity of SSeCKS protein observed was signi®cantly reduced in v-Jun transformed 10T1/2 cells ( Figure 6 ).
Expression of SSeCKS in v-Jun-transformed 10T1/2 cells attenuates the transformed phenotype
The role of SSeCKS in Jun-induced transformation was examined by re-expressing the down-regulated protein in v-Jun-transformed cells. The murine SSeCKS cDNA was cloned into the p-Babe-hygro vector (Lin and Gelman, 1997) and v-Jun-transformed 10T1/2 cells were superinfected and selected as were cells infected with empty p-Babe-hygro 10T1/2. Western blots were performed to con®rm that SSeCKS was being expressed (Figure 6 ). v-Jun-infected cells were also superinfected with p-Babe-hygro virus, followed by hygromycin selection to ensure that results were not an artifact of the hygromycin selection process. The morphology of v-Jun-transformed 10T1/ 2 cells was not altered by reexpression of SSeCKS. However, the saturation density of SSeCKS-expressing v-Jun-transformed 10T1/2 cells was signi®cantly reduced. Control 10T1/2 cells expressing SSeCKS showed the same saturation density as p-Babe-infected 10T1/2 (Figure 2 ) v-Jun 10T1/2 cells expressing SSeCKS also formed signi®cantly fewer foci than vJun transformants with down-regulated SSeCKS. Focus-forming eciencies of SSeCKS expressers were similar to those of control p-Babe infected 10T1/2 cells, or of 10T1/2 cells expressing SSeCKS alone. These Figure 4 v-Jun-expression in 10T1/2 cells leads to anchorageindependent growth that is attenuated by SSeCKS expression. The cells used were the same as described in Figures 1 and 2 . 1.25610 4 cells were suspended in 2 ml of 0.35% nutrient agar in 60 mm plates that contained 3 ml of pre-cast 0.7% agar. Cells were fed every 5 days, and after 4 weeks were photographed. Table 1 shows the quanti®cation of this experiment Oncogene V-Jun down regulated SSeCKS in murine fibroblasts SB Cohen et al results suggest that SSeCKS can partially reestablish the contact inhibition of growth that is lost during vJun-induced transformation. v-Jun 10T1/2 cells expressing SSeCKS cells also showed an about 10-fold reduced plating eciency in agar. The colonies formed by these cells were also signi®cantly smaller than colonies of v-Jun-transformed 10T1/2 cells ( Figure 4 and Table 1 ). Expression of SSeCKS by itself had no eect on anchorage-independent growth; SSeCKS cells behaved identical to p-Babe-infected 10T1/2 cells. vJun-transformed 10T1/2 cells were also super-infected with p-Babe-hygro virus, followed by hygromycin selection. These cells showed the growth and transformation phenotype of the v-Jun-10T1/2 cells, demonstrating that hygromycin selection did not contribute to the observed eects of SSeCKS (data not shown).
Discussion
Oncogenic transcription factors induce transformation by altering the normal controls of gene expression in the cell. Aberrant regulation of speci®c target genes initiates and maintains cellular properties that constitute the oncogenic phenotype. Identi®cation and characterization of these critical oncogenic targets has become the Holy Grail in basic cancer research. DNA micro-array technology oers powerful tools for the identi®cation of genes that are dierentially expressed in cancer cells. At present, the application of these tools is limited to cells of mouse and man. For other vertebrate species, the available genomic information is as yet insucient to produce comprehensive arrays. Yet oncogenic transcription factors that are potent transformers of avian cells generally fail to aect primary mouse cells, although they can transform continuous rodent cell lines that presumably have undergone some preneoplastic changes (Alt and Grassmann, 1993; Colledge et al., 1989; Land et al., 1986; Schreiber-Agus et al., 1993; Sterneck et al., 1992; Weinstein et al., 1986) . There is therefore an urgent need for murine transformation systems driven by transcription factor oncoproteins. The 10T1/2 cells infected by the v-Jun expressing vector have all the hallmarks of cancer cells. They are morphologically altered, grow in multi-layered foci, show increased saturation density and have acquired the ability of anchorage-independent growth.
In the course of these studies, several types of murine ®broblasts carrying null mutations in key tumor suppressor genes were also tested for their susceptibility to transformation by v-Jun. v-Jun induced anchorage-independent growth in cells lacking the p53 gene but failed to transform murine cells defective in the Rb or p21 genes. v-Jun was also poorly expressed in these latter cell types, in contrast to 10T1/ 2 cells which showed high levels of v-Jun (SB Cohen, 2000, unpublished observations).
The number of dierentially expressed genes detected by DNA arrays in cancer cells is typically very large (Alizadeh and Staudt, 2000; Pollack et al., 1999; Wang et al., 2000; Xu et al., 2000) , and the v-Jun-transformed 10T1/2 cells are no exception. Probably only a small set of these targets is in control of neoplastic properties. Identifying these critical actors and distinguishing them from innocent bystanders with functional tests is a laborious and time-consuming task. One justi®able criterion for the initial selection of targets to be characterized is the degree of dierential expression. Genes that are highly up or down-regulated are perhaps more likely to aect the cellular phenotype. SSeCKS is one such highly misregulated gene; North- Compared to vector infected 10T1/2 cells Figure 5 Transcription of ssecks is down-regulated in v-Juntransformed 10T1/2 cells. A Northern blot was prepared using 2 mg of poly(A) + RNA from 10T1/2 cells infected with (1) pBabe-puro or (2) p-Babe-puro-VJ1. Sample 3 is from an individual agar colony of v-Jun-transformed 10T1/2 cells Figure 6 SSeCKS expression is down-regulated in v-Jun transformed 10T1/2 cells. A Western blot was prepared for 50 mg of whole cell lysates from 10T1/2 cells infected with (1) p-Babe-puro, (2) p-Babe-hgro-SSeCKS, (3) p-Babe-puro-VJ1, or (4) p-Babepuro-VJ1 and p-Babe-hygro-SSeCKs ern blots show its expression lowered by a factor of more than 10 in v-Jun-transformed 10T1/2 cells. Previous studies had also identi®ed the product of the SSeCKS gene as a potential tumor suppressor (Lin and Gelman, 1997) . The SSeCKS protein of rodents shows homology to a human protein recognized by an auto-antibody in myasthenia gravis and termed`gravin' (Nauert et al., 1997) . These proteins share two domains, one mediating interaction with protein kinase C (PKC) and the other with the regulatory subunit of protein kinase A. SSeCKS is therefore likely to play a role in several signaling cascades; it could also function as a bridge connecting two pathways. SSeCKS expression is also down-regulated in rodent cells transfected by Src, Ras, Fos or Myc, but shows no change in expression in cells expressing Raf, Mos or Neu (Lin et al., 1995) . These facts suggest a convergence of dierent oncogenic pathways and reinforce the role of SSeCKS as a tumor suppressor. Whereas certain oncogenes can transform without aecting SSeCKS expression Jun, Src, Ras, Fos, and Myc may perhaps require down regulation of SSeCKS to eect transformation. In the case of Src and Jun, the re-introduction of SSeCKS can, at least in part, block transformation.
Re-expression of SSeCKS partially reverses the transformed phenotype of v-Jun-transformed 10T1/2 cells. This result suggests that down-regulation of SSeCKS is a requirement for Jun-induced oncogenic transformation. SSeCKS functions as a tumor suppressor counteracting the oncogenic eect of Jun as well as Src (Lin and Gelman, 1997) . SSeCKS is the second identi®ed Jun target that by itself can aect the growth behavior of the cell. The other one, heparin binding epithelial growth factor (HB-EGF), is up-regulated in Jun-transformed CEF and induces a partial transformation when overexpressed in CEF. Over-expression of HB-EGF in 10T1/2 cells does not cause transformation (SB Cohen, 1999, unpublished observations) . Down-regulation of SSeCKS is probably not sucient to induce cellular transformation; dierential expression of other Jun targets may be required for this process. The attenuating eect of reexpressing SSeCKS on the transformed phenotype is reminiscent of other tumor suppressor genes. Colon cancer cell lines carry mutations in several growth-regulatory genes including both loss and gain of functions, yet reversion of transformation can be achieved by reintroducing a single tumor suppressor, the adenomatous polyposis coli (APC) gene, into these cells (Groden et al., 1995) . Loss of APC function is an early event in polyp formation and is insucient to cause colon cancer. Progression from polyp to malignant tumor requires additional mutations including loss of function in p53 and gain of function in Ras (Cho and Vogelstein, 1992) . Similarly, Jun-transformed cells will contain other up and down-regulated genes that are necessary, but individually are not sucient for transformation.
SSeCKS is a substrate of PKC. The DNA microarrays also identi®ed another down-regulated PKC substrate, myristylated alanine-rich C kinase substrate (MARCKS). Like SSeCKS, it has an attenuating eect on the transformed cellular phenotype (SB Cohen, 2000, in preparation) . Interference with PKC signals may therefore be an important aspect of Jun-induced transformation.
Materials and methods
Recombinant vectors
pBabe-puro-VJ1 was generated by excising the ClaI fragment from RCAS-VJ1 (Bos et al., 1990) and subcloning into the BstB1 site of a modi®ed pBabe-puro vector (Morgenstern and Land, 1990 ) that contains the multi-cloning site of MCS5 (BamHI to HpaI) cloned into BamHI/SnaBI. The pBabehygro-SSeCKS vector has been described previously (Lin and Gelman, 1997) .
Cell culture, transfection, saturation density, focus assays and soft agar cloning BOSC23 and PA317 cells are ecotropic and amphotopic retroviral packaging lines, respectively (Miller and Rosman, 1989; Pear et al., 1993) . 10T1/2 cells are a continuous line of normal murine ®broblasts (Rezniko et al., 1973) . All three cell lines were obtained from the laboratory of Edward Stavnezer. BOSC23, PA317 and 10T1/2 cells were grown in DMEM/high glucose medium with glutamine (Gibco) containing 10% fetal calf serum, 10 mg/ml gentamicin, 2 mg/ ml amphotercin B (Sigma), 10 mM HEPES. Transient transfections of BOSC23 cells were performed using the DOTAP liposome reagent according to the manufacturer's instructions (Boehringer Mannheim Corp.). Infectious virus was harvested 24 h post transfection, passed through a 0.2 m syringe ®lter, and applied to either PA317 (VJ1) or 10T1/2 cells (SSeCKS). PA317-VJ1 cells were selected with puromycin (2.5 mg/ml) for 5 days, and from the surviving cells infectious virus was again harvested and used to infect 10T1/ 2 cells. 10T1/2 cells were selected in either puromycin (VJ1) at 3.0 mg/ml or hygromycin B (SSeCKS) at 75 mg/ml. SSeCKS expression had a toxic eect on PA317, therefore virus was used directly from the BOSC23 packaging line. 10T1/2 cells expressing v-Jun were superinfected with SSeCKS virus or pBabe-hygro virus in an analogous manner, as were individual p-Babe-puro and pBabe-hygro controls.
Saturation density was determined by plating 2610 4 cells in 12 35 mm plates. Each day the cells in one plate were trypsinized and counted. Focus assays were performed by diluting the appropriate cells at 1/50 or 1/200 with p-Babe infected cells, and seeding 2.5610 5 total cells in 35 mm plates. Medium was changed every third day, and cells were allowed to grow for 10 days when they were stained in 2% crystal violet in 20% methanol for 1 min and destained in 1% acetic acid, 1% methanol for 2 min. Soft agar cloning followed published techniques, using 1.25610 4 cells in a 60 mm plate (Colmenares et al., 1991) . Cells were fed every 5 days, and colonies were counted after 4 weeks. Saturation density, focus assays and soft agar cloning were repeated at least once using a VJ1/p-Babe-hygro co-infected 10T1/2 cells to ensure that eects seen were not the result of hygromycin selection.
Northern blots
The preparation of total RNA, poly(A) + RNA and Northern blots has been previously described (Fu et al., 1999) .
Western blots
10T1/2 cells were lysed in RIPA buer (150 nM NacL/ 100 mM Tris HCl pH 8.0, 1%. Triton X-100, 1% deoxycholic acid, 5 mM EDTA, 1 mM PMSF, 0.5 mM DTT). The lysates were clari®ed by centrifugation at 15 0006g for 10 min. Aliquots containing 50 mg of protein were resolved by SDS ± PAGE and transferred to PVDF in 20 mM TRIS-HCl pH 8.0, 150 mm glycine, 120% (vol/vol) methanol. Membranes were blocked with 5% nonfat dry milk in PBS, 0.05% Tween 20 buer and incubated with a rabbit antibody speci®c for SSeCKS (Lin et al., 1996) . Protein bands were visualized by incubating with a horseradish peroxidase conjugated secondary antibody (Amersham) and were detected by incubating with a chemiluminescent substrate per manufacturer's protocol (Dupont/NEN).
